The FDA has updated the label indication for linaclotide capsules for the treatment of irritable bowel syndrome with ...
The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...
The FDA has approved Linzess (linaclotide) for children aged 7 and older with IBS-C, marking the first FDA-approved drug for ...
MedPage Today on MSN
FDA Approves First Drug for Kids' Irritable Bowel Syndrome With Constipation
Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...
The US Food and Drug Administration (FDA) has approved Linzess (linaclotide) as the first treatment for children living with ...
FDA approves IBS drug for children, Linzess, to treat pediatric IBS-C in patients ages 7 and older with proven safety and efficacy.
The US medicines regulator has approved Linzess (linaclotide) capsules for children aged seven years and older with irritable ...
Around a third of children in the UK will experience some form of constipation - but what is it, and how can you help?
The Institute of Health Visiting (iHV) has published new guidance on toilet training to help tackle ‘unnecessary delays’ ...
The FDA has approved linaclotide (Linzess) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation, according to a Nov. 5 news release. Linzess is the first ...
Ironwood Pharmaceuticals (IRWD) stock gains as the FDA approves a label expansion for the company's AbbVie (ABBV)-partnered ...
Big-gun pain relievers can come with unwelcome side effects. At the top of the list for many of these products are constipation and the distress of slowed bowels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback